Bacterial lipodipeptide, Lipid 654, is a microbiome‐associated biomarker for multiple sclerosis V Farrokhi, R Nemati, FC Nichols, X Yao, E Anstadt, M Fujiwara, J Grady, ... Clinical & translational immunology 2 (11), e8, 2013 | 100 | 2013 |
Association of antibiotic exposure with survival and toxicity in patients with melanoma receiving immunotherapy JJ Mohiuddin, B Chu, A Facciabene, K Poirier, X Wang, A Doucette, ... JNCI: Journal of the National Cancer Institute 113 (2), 162-170, 2021 | 95 | 2021 |
Serine lipids of Porphyromonas gingivalis are human and mouse Toll-like receptor 2 ligands RB Clark, JL Cervantes, MW Maciejewski, V Farrokhi, R Nemati, X Yao, ... Infection and immunity 81 (9), 3479-3489, 2013 | 78 | 2013 |
Bridging radiation therapy before commercial chimeric antigen receptor T-cell therapy for relapsed or refractory aggressive B-cell lymphoma CM Wright, MJ LaRiviere, JA Baron, C Uche, Y Xiao, WT Arscott, ... International Journal of Radiation Oncology* Biology* Physics 108 (1), 178-188, 2020 | 71 | 2020 |
Deposition and hydrolysis of serine dipeptide lipids of Bacteroidetes bacteria in human arteries: relationship to atherosclerosis R Nemati, C Dietz, EJ Anstadt, J Cervantes, Y Liu, FE Dewhirst, RB Clark, ... Journal of lipid research 58 (10), 1999-2007, 2017 | 43 | 2017 |
TLR tolerance as a treatment for central nervous system autoimmunity EJ Anstadt, M Fujiwara, N Wasko, F Nichols, RB Clark The Journal of Immunology 197 (6), 2110-2118, 2016 | 42 | 2016 |
Serine dipeptide lipids of Porphyromonas gingivalis inhibit osteoblast differentiation: Relationship to Toll-like receptor 2 YH Wang, R Nemati, E Anstadt, Y Liu, Y Son, Q Zhu, X Yao, RB Clark, ... Bone 81, 654-661, 2015 | 36 | 2015 |
Enhanced TLR2 responses in multiple sclerosis M Fujiwara, EJ Anstadt, B Flynn, K Morse, C Ng, P Paczkowski, J Zhou, ... Clinical & Experimental Immunology 193 (3), 313-326, 2018 | 33 | 2018 |
Mesenchymal stromal cells are present in the heart and promote growth of adult stem cells in vitro EB Lushaj, E Anstadt, R Haworth, D Roenneburg, J Kim, P Hematti, ... Cytotherapy 13 (4), 400-406, 2011 | 33 | 2011 |
Cbl-b deficiency mediates resistance to programmed death-ligand 1/programmed death-1 regulation M Fujiwara, EJ Anstadt, RB Clark Frontiers in Immunology 8, 235438, 2017 | 32 | 2017 |
The role of phospholipase A2 in multiple Sclerosis: A systematic review and meta-analysis A Trotter, E Anstadt, RB Clark, F Nichols, A Dwivedi, K Aung, ... Multiple sclerosis and related disorders 27, 206-213, 2019 | 16 | 2019 |
Gender-based disparities in receipt of care and survival in malignant pleural mesothelioma AR Barsky, CA Ahern, S Venigalla, V Verma, EJ Anstadt, CM Wright, ... Clinical Lung Cancer 21 (6), e583-e591, 2020 | 13 | 2020 |
Cbl-b-deficient mice express alterations in trafficking-related molecules but retain sensitivity to the multiple sclerosis therapeutic agent, FTY720 M Fujiwara, EJ Anstadt, KM Khanna, RB Clark Clinical Immunology 158 (1), 103-113, 2015 | 9 | 2015 |
Simultaneous determination of absolute configuration and quantity of lipopeptides using chiral liquid chromatography/mass spectrometry and diastereomeric internal standards R Nemati, C Dietz, E Anstadt, R Clark, M Smith, F Nichols, X Yao Analytical chemistry 89 (6), 3583-3589, 2017 | 7 | 2017 |
Mitochondrial DNA deletion mutations in adult mouse cardiac side population cells EB Lushaj, L Lozonschi, M Barnes, E Anstadt, T Kohmoto Mutation Research/Fundamental and Molecular Mechanisms of Mutagenesis 734 (1 …, 2012 | 7 | 2012 |
Single community-based institutional series of stereotactic body radiation therapy (SBRT) for treatment of liver metastases EJ Anstadt, R Shumway, J Colasanto, D Grew Journal of Gastrointestinal Oncology 10 (2), 330, 2019 | 4 | 2019 |
Moderate colitis not requiring intravenous steroids is associated with improved survival in stage IV melanoma after anti-CTLA4 monotherapy, but not combination therapy EJ Anstadt, B Chu, N Yegya-Raman, X Han, A Doucette, K Poirier, ... The Oncologist 27 (9), 799-808, 2022 | 3 | 2022 |
Radiation therapy for plasma cell disease of the brain and skull: poor palliation and survival after treatment for central nervous system involvement GR Williams, AA Butala, SH Manjunath, RJL Maxwell, EJ Anstadt, ... Advances in Radiation Oncology 6 (4), 100720, 2021 | 2 | 2021 |
Initial clinical experience treating patients with lung cancer on a 6MV-flattening-filter-free O-ring linear accelerator AR Barsky, H Lin, A Mendes, A Dreyfuss, C Wright, EJ Anstadt, ... Cureus 12 (9), 2020 | 2 | 2020 |
Initial clinical experience treating patients with palliative radiotherapy for malignant pleural mesothelioma on the HalcyonTM linear accelerator AR Barsky, MM Kim, R Maxwell, A Mendes, CM Wright, EJ Anstadt, ... Annals of Palliative Medicine 9 (5), 2903912-2902912, 2020 | 2 | 2020 |